Biogen Idec’s executive vice president of Research & Development, Douglas Williams said it best: “What’s hot in biotech? I’d say damn near everything.”
Williams, of course, was kicking off the festivities at Xconomy Boston’s latest life sciences event, “What’s Hot in Boston Biotech,” on April 16. Attendees then got a taste of the big ideas floating around the local biotech scene, from gene editing to “super-enhancers” to microbiome drug cocktails. Last week I posted a recap of the event, and today I’m circling back with some of the photos.
Once again, a tip of the cap to KeithSpiroPhoto, courtesy of Kendall Press, for all the pictures. And a big thank you to our speakers, our event host, Biogen, and our sponsors: Cubist Pharmaceuticals; Health Advances; Icon; Mintz Levin; and Rasky Baerlein. And a special thanks to our National Partner, Alexandria Real Estate Equities.
Ben Fidler is Xconomy's Deputy Biotechnology Editor. You can e-mail him at firstname.lastname@example.org